scPharmaceuticals Inc
NASDAQ:SCPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
scPharmaceuticals Inc
NASDAQ:SCPH
|
US |
|
W
|
WIIK PCL
SET:WIIK
|
TH |
|
C
|
Clearmind Medicine Inc
CNSX:CMND
|
CA |
|
T
|
Toyota Tsusho Corp
F:9TO
|
JP |
|
Thomson Reuters Corp
F:TOC
|
CA |
|
Medmix Ltd
SIX:MEDX
|
CH |
|
B
|
Bifire SpA
MIL:FIRE
|
IT |
|
Seanergy Maritime Holdings Corp
F:RHS
|
GR |
|
P
|
Persimmon PLC
F:OHP
|
UK |
|
RCI Hospitality Holdings Inc
NASDAQ:RICK
|
US |
|
Brainstorm Cell Therapeutics Inc
F:GHDN
|
US |
|
I
|
Insun Environmental New Technology Co Ltd
KOSDAQ:060150
|
KR |
|
SBW
KRX:102280
|
KR |
|
Chimeric Therapeutics Ltd
ASX:CHM
|
AU |
|
Ampd Ventures Inc
OTC:AMPDF
|
CA |
|
U
|
United Overseas Bank Ltd
XMUN:UOB
|
SG |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SCPH's stock price target?
Not Available
SCPH does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for scPharmaceuticals Inc?
Projected CAGR
74%
The compound annual growth rate for Revenue over the next 3 years is 74%.